Published in:
01-08-2012 | ASSISTED REPRODUCTION TECHNOLOGIES
Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels
Anti-Müllerian hormone in poor responders in assisted reproductive treatment
Published in: Journal of Assisted Reproduction and Genetics | Issue 8/2012
Login to get accessAbstract
Objective
To evaluate the predictive value of random serum anti-Müllerian hormone (AMH) in the assessment of ovarian response in patients with diminished ovarian reserve (DOR; diagnosed after the observation of elevated baseline levels of early follicular follicle-stimulating hormone [FSH]) who were undergoing intracytoplasmic sperm injection-embryo transfer (ICSI-ET) and to compare the random serum AMH and baseline FSH levels in these patients for the prediction of poor ovarian response.
Design
Retrospective study.
Setting
University hospital.
Patients
One hundred and thirty-nine patients who were undergoing ICSI-ET cycles with early follicular FSH level >9 IU/mL.
Intervention(s)
None.
Main Outcome Measure(s)
Poor ovarian response in ICSI-ET cycles.
Results
For the identification of women at risk of cycle cancellation, an AMH cut-off level ≤1.2 ng/mL had 97.3 % sensitivity, 31.3 % specificity, 33.9 % positive predictive value, and 96.9 % negative predictive value in the women with high baseline FSH levels. An AMH cut-off level ≥1 ng/mL had a sensitivity of 58.7 % and specificity of 95.1 % for prediction of retrieval of 4 or more oocytes. By using a serum AMH cutoff level of 1.5 ng/mL, the ongoing pregnancies were predicted with 83.3 % sensitivity and 82.5 % specificity and yielded a positive predictive value of 31.2 % and a negative predictive value 98.1 %.
Conclusion
Measurement of random serum AMH level is a useful tool in the prediction of ovarian response in patients with high serum early follicular FSH levels.